First Washington Corp’s Viking Therapeutics VKTX Stock Holding History

First Washington Corp's VKTX Position: Q2 2026 in Review

First Washington Corp reduced its Viking Therapeutics (VKTX) stake by 1.1% in Q2 2026, selling an estimated $131K and leaving 381,300 shares worth $14.9M. The position accounts for 3.62% of the portfolio, ranked #6.

First Washington Corp first reported a position in VKTX in Q4 2023 and has held it in 11 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

• First Washington Corp held 381,300 shares of Viking Therapeutics worth $14.9M as of Q2 2026.
• First Washington Corp sold 4,066 Viking Therapeutics shares in Q2 2026, an estimated $131K.
• Viking Therapeutics made up 3.62% of First Washington Corp's portfolio in Q2 2026, its #6 holding.
• First Washington Corp first reported a position in Viking Therapeutics in Q4 2023 and has held it in 11 quarters since.
• 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on First Washington Corp's 13F filing for Q2 2026, filed 13 Aug 2026.